NCT02232594View on ClinicalTrials.gov

Postmarketing Surveillance Study of Berodual® Metered-dose Inhaler in Chronic Obstructive Respiratory Tract Disease

CompletedOBSERVATIONAL
Enrollment

834

Participants

Timeline

Start Date

January 31, 2000

Primary Completion Date

December 31, 2000

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Berodual®

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY